Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2015 Jul 16;59(8):5088–5091. doi: 10.1128/AAC.00420-15

Relative Strengths of Promoters Provided by Common Mobile Genetic Elements Associated with Resistance Gene Expression in Gram-Negative Bacteria

Muhammad Kamruzzaman 1, Jason D Patterson 1, Shereen Shoma 1, Andrew N Ginn 1, Sally R Partridge 1, Jonathan R Iredell 1,
PMCID: PMC4505201  PMID: 26055385

Abstract

Comparison of green fluorescent protein expression from outward-facing promoters (POUT) of ISAba1, ISEcp1, and ISAba125 revealed approximate equivalence in strength, intermediate between PCS (strong) and PCWTGN-10 (weak) class 1 integron promoter variants, >30-fold stronger than POUT of ISCR1, and >5 times stronger than Ptac. Consistent with its usual role, PCWTGN-10 produces more mRNA from a “downstream” gfp gene transcriptionally linked to a “usual” PCWTGN-10-associated gene cassette than does POUT of ISAba1.

TEXT

Antibiotic resistance genes in Gram-negative bacteria are generally associated with mobile genetic elements (MGE) such as transposons, integrons, and insertion sequences (IS) (1). These MGE typically provide the promoter responsible for resistance gene expression, and as each different resistance gene is generally associated with one particular MGE (1), the strength of the MGE promoter is expected to be a major determinant of the level of antibiotic resistance.

Complete outward-facing promoters (POUT) have been identified in many IS, including ISAba1 (2), ISEcp1 (3), and ISCR1 (4), which are associated with a variety of important resistance genes (1). Some IS include only a partial promoter; for example, ISAba125 provides only a −35 element in the right terminal inverted repeat, a new promoter being generated when this IS inserts itself at the correct distance from a −10 element (5). Gene cassettes captured by class 1 integrons are expressed from a common promoter (Pc), sometimes in combination with a secondary promoter (P2) (6, 7). The relative strengths of several Pc variants have been described previously (612), but a direct systematic comparison with POUT of various IS has not been made.

We therefore measured the relative expression of green fluorescent protein (GFP) from POUT promoters of some important IS (ISAba1, ISAba125, ISEcp1, and ISCR1) and two Pc variants from class 1 integrons (without an active P2), PcS (“strong”) and PcWTGN-10 (a variant of the “weak” version of Pc with an extended −10 motif that increases the PcW efficiency [9]), in both Escherichia coli and Klebsiella pneumoniae. Each promoter was amplified from a suitable isolate (see Table S1 in the supplemental material) with primers containing specific restriction sites (see Table S2), the blaNDM-1 −10 region being included in the case of ISAba125, and cloned into the unique BamHI site of low-copy-number promoter detection vector pANT3 (13) to direct the expression of gfpmut3 (gfp here) (Table 1; see Fig. S1 in the supplemental material). Sequencing confirmed a single copy of each promoter in the correct orientation.

TABLE 1.

Plasmids used in this study

Plasmid Characteristic(s) Reference
pANT3 Low-copy-number, broad-host-range cloning vector; Kanr, gfpmut3 with no promoter 13
pANT5 Low-copy-number, broad-host-range cloning vector; Kanr, gfpmut3 gene under control of tac promotera 13
pJIBE401 Naturally occurring conjugative IncL/M plasmid from Kp1239 containing blaIMP-4 qacG aacA4 catB3 in a class 1 integron 14
pJIJP001 pANT3 with 210-bp fragment containing POUT from ISAba1 inserted into BamHI site upstream of gfpmut3 This work
pJIJP002 pANT3 with 238-bp fragment containing POUT from ISEcp1 inserted into BamHI site upstream of gfpmut3 This work
pJIJP003 pANT3 with 251-bp fragment containing POUT from ISCR1 inserted into BamHI site upstream of gfpmut3 This work
pJIJP004 pANT3 with 245-bp fragment containing class 1 integron PCWTGN-10 promoter inserted into BamHI site upstream of gfpmut3 This work
pJIJP005 pANT3 with 245-bp fragment containing class 1 integron PCS promoter inserted into BamHI site upstream of gfpmut3 This work
pJISS125 pANT3 with 120-bp fragment containing −35 from ISAba125 and −10 from blaNDM inserted into BamHI site upstream of gfpmut3 This work
pJIMK007 pANT3 with 1,040-bp PCWTGN-10-blaIMP-4 region from pJIBE401 inserted into BamHI and XbaI sites This work
pJIMK51 pJIJP001 with 808-bp fragment containing blaIMP-4 inserted into XbaI site between gfpmut3 and POUT from ISAba1 This work
pJIMK52 pJIJP003 with 808-bp fragment containing blaIMP-4 inserted into XbaI site between gfpmut3 and POUT from ISCR1 This work
a

Sequencing of the trp-lac (tac) fusion promoter region of pANT5 (with primer U-GFP-R1; see Table S2 in the supplemental material) revealed a “standard” tac promoter sequence, corresponding to nucleotides 20 to 92 of the 96-bp HindIII/BamHI fragment previously used by Lévesque et al. (6) as a comparator for Pc.

E. coli DH5α and K. pneumoniae ATCC 13883 containing a promoter construct or with pANT3 (promoterless gfp) or pANT5 (Ptac-gfp) were incubated overnight (16 h, stationary phase) at 37°C on nutrient agar with 50 μg/ml kanamycin and suspended in phosphate-buffered saline (PBS) adjusted to ∼1.5 × 108 CFU/ml, as estimated with a nephelometer. Fluorescence was measured with a Victor 3 plate reader (PerkinElmer) with an excitation wavelength of 485 nm and an emission wavelength of 535 nm. Experiments were performed in triplicate on three separate occasions, and the mean and standard deviation were calculated (Fig. 1). Univariate analysis of variance (ANOVA) showed a statistically significant interaction (P < 0.001) between fluorescence intensities for promoters and species, indicating that results for each species should be considered separately. All further statistical analysis of multiple variables was performed by one-way ANOVA with Bonferroni's correction (SPSS v18; IBM Inc.). A P value of <0.05 was considered statistically significant.

FIG 1.

FIG 1

Relative GFP expression in E. coli DH5α (black) and K. pneumoniae ATCC 13883 (white) from control isolates (no plasmid) (A), promoter-gfp constructs (B), and promoter-blaIMP-4-gfp constructs (C) in stationary phase. Fluorescence values are the means of nine data points; error bars indicate 1 standard deviation from the mean. The only significant (P < 0.05) differences in expression between species for the same promoter were for ISAba1 with or without blaIMP-4 and ISEcp1. Differences in expression from different promoters were all significant (P < 0.05), except among ISAba1, ISEcp1, and ISAba125 in E. coli, between PcWTGN-10 with and without blaIMP-4 inserted in E. coli, and among ISCR1 (with or without blaIMP-4), no plasmid, and no promoter. Abs, absorbance.

The relative GFP expression from the different promoters was PcS > ISEcp1 POUT ≈ ISAba125 POUT ≈ ISAba1 POUT > PcWTGN-10 ≫ ISCR1 POUT (Fig. 1B) in both species, and in agreement with published data, the GFP fluorescence intensity from PcS was approximately 1.8-fold higher than that from PcWTGN-10 (P < 0.001) (9) and ∼6.5-fold higher than that from the common tac expression promoter (6). PcS was 38-fold and PcWTGN-10 was 21-fold stronger than ISCR1 POUT (P < 0.001) in both species. In E. coli, there was no significant difference among the relative strengths of ISAba1, ISAba125, and ISEcp1 POUT (P > 0.05). These three promoters were 32-fold stronger than ISCR1 POUT (P < 0.001) and 5.5-fold stronger than the tac promoter. GFP expression in exponential phase (measured with ∼1.5 × 108 CFU/ml in PBS from cultures grown at 37°C for 3 h in LB with 50 μg/ml kanamycin after dilution from an overnight culture) was not significantly different (see Fig. S2 in the supplemental material) from that in stationary phase.

The cassette-borne blaIMP-4 gene encodes a metallo-β-lactamase that is expressed from PCWTGN-10 in its native genetic context in pJIBE401 from K. pneumoniae Kp1239 (14) (GenBank accession no. AJ609296). To further understand the clinical relevance of promoter variation, blaIMP-4 was inserted between selected promoters and gfp. In pJIBE401, the blaIMP-4 gene is followed by 127 bp of the blaIMP-4 attC site, which forms a stem-loop that may reduce the expression of downstream genes by impeding ribosome progression (15), and the transcriptionally coupled qacG gene cassette (14). PCWTGN-10 with the complete blaIMP-4 gene, but not the downstream part of the attC site, was amplified from the native context in pJIBE401 with primers containing BamHI and XbaI sites (see Table S2 and Fig. S1 in the supplemental material) and cloned into these sites in pANT3 to generate pJIMK007 (Table 1). Primers including XbaI sites were used to amplify blaIMP-4 with its native ribosome binding site (RBS) but none of the downstream attC site (see Table S2 and Fig. S1) for cloning into the XbaI site of pJIJP001 (ISAba1) and pJIJP003 (ISCR1) promoter constructs to generate pJIMK51 and pJIMK52, respectively.

The blaIMP-4 and gfp mRNA levels were measured from promoter-blaIMP-4-gfp constructs by quantitative reverse transcriptase PCR (qRT-PCR). One milliliter of exponential-phase culture (as described above, optical density at 600 nm [OD600] of 0.4) was added to 2.0 ml of RNAprotect Bacteria Reagent (Qiagen), and RNA was extracted from cell pellets (RNeasy minikit, Qiagen) and treated with RNA-free TURBO DNase and then DNase Inactivation Reagent (Ambion), all according to the manufacturers' instructions. PCR with qRT-PCR primers (see Table S2 in the supplemental material) was performed to exclude contaminating DNA. RNA (1 μg, OD260/280 ratio of 1.9 to 2.1) was converted to cDNA by RT-PCR (MultiScribe RT) and amplified (Power SYBR green PCR master mix [Applied Biosystems]; 95°C for 5 min and 40 cycles of 95°C for 5 s and 60°C for 10 s). mRNA levels, calculated by the ΔCT method (16), were normalized to rpoB expression (see Table S2). Experiments were performed in triplicate, and mean values and standard deviations were calculated. Relative blaIMP-4 and gfp mRNA expression from PCWTGN-10 and ISCR1 in both E. coli and K. pneumoniae (see Fig. S3 in the supplemental material) was consistent with GFP expression (Fig. 1C). blaIMP-4 and gfp mRNA expression from ISAba1 (see Fig. S3) was also consistent with GFP fluorescence data but differed between the two species (Fig. 1C).

Interposition of blaIMP-4 between gfp and the promoter had no effect on expression from PCWTGN-10 in either E. coli or K. pneumoniae, but GFP, gfp, and blaIMP-4 mRNA expression from ISAba1 POUT was lower than that obtained with PCWTGN-10 after the interposition of blaIMP-4 (Fig. 1; see Fig. S3 in the supplemental material), despite the presence of the same sequence between blaIMP-4 and gfp (see Fig. S1). For all constructs with blaIMP-4, the influence of promoter strength on imipenem MICs (determined by Etest; Liofilchem, Roseto degli Abruzzi, Italy) was less striking (Table 2) but was also consistent with GFP fluorescence data (Fig. 1C). The ISCR1|blaIMP-4 construct did not significantly exceed the clinically defined MIC (17) beyond which therapeutic failure is predicted, even when expressed from this multicopy pANT plasmid. It is noteworthy that resistance genes found in association with ISCR1 typically have their own promoter (18).

TABLE 2.

Imipenem MICs for blaIMP-4 with different promoters

Bacterial strain and plasmid Promoter MIC (μg/ml)
E. coli DH5α
    None None 0.125
    pJIMK007 PCWTGN-10 3
    pJIMK51 ISAba1 2
    pJIMK52 ISCR1 0.75
K. pneumoniae ATCC 13883
    None None 0.38
    pJIMK007 PCWTGN-10 4
    pJIMK51 ISAba1 3
    pJIMK52 ISCR1 1

Differences in replication and transcription machinery (19), codon preferences, and tRNA availability (20) may result in different levels of expression from identical promoters in different species. Expression of an Acinetobacter baumannii blaADC (ampC) gene (determined by qRT-PCR) was reported to be ∼2-fold higher from ISAba125 than from ISAba1 (21), and GFP expression from ISAba1 and ISEcp1 POUT was significantly lower in K. pneumoniae ATCC 13883 than in E. coli DH5α in our own experiments, although these differences were less striking than the differential effects of gene interposition. PC promoters are found in a distinctive genetic context, usually with a tandem array of cassette-borne genes (four in pJIBE401 from clinical isolate Kp1239) that rely on them for expression, while IS promoters such as ISAba1 POUT are typically found upstream of a single gene that requires a shorter transcript for expression. Differential effects on polymerase processivity are known to result in different proportions of long transcripts from different promoters, despite very similar amounts of short transcripts from these same promoters (2224). It is noteworthy that the relative expression of gfp mRNA was around twice that of blaIMP-4 mRNA from all three promoter-blaIMP-4-gfp constructs in both E. coli and K. pneumoniae (see Fig. S3 in the supplemental material), implicating additional processes such as RNase E-mediated degradation (25, 26) that may selectively modulate the expression of operon genes (27). The finding that PCWTGN-10 produces more blaIMP-4 and gfp mRNA than ISAba1 (see Fig. S3) is consistent with minor MIC differences (Table 2), with a usual connection of PCWTGN-10 with blaIMP-4 and similar gene cassettes, and with a usual role for PCWTGN-10 in the production of longer transcripts (gene cassette arrays) but contrasts with the apparently slightly greater potency of the ISAba1 promoter, as judged by GFP expression (Fig. 1).

Our findings are overall consistent with and extend previously published work. We show here that common MGE-associated promoters of resistance gene expression are generally stronger than familiar workhorses such as Ptac (28) with similar levels of expression of the proximate gene. Links between resistance genes and promoters in MGE are predictable and clearly important when considering the expression of a new resistance gene as it emerges in the mobile gene pool, but it is equally clear that the host strain, and especially the genetic context, should be carefully considered when making comparisons between promoters.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

We thank Karen Byth for help with statistical analysis.

M.K. and S.S. are supported by Centre of Research Excellence grant G1001021, A.N.G. is supported by grant G1046886, and J.R.I. is supported by grant PF1002076 from the National Health and Medical Research Council of Australia.

Footnotes

Supplemental material for this article may be found at http://dx.doi.org/10.1128/AAC.00420-15.

REFERENCES

  • 1.Partridge SR. 2011. Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiol Rev 35:820–855. doi: 10.1111/j.1574-6976.2011.00277.x. [DOI] [PubMed] [Google Scholar]
  • 2.Segal H, Nelson EC, Elisha BG. 2004. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother 48:612–614. doi: 10.1128/AAC.48.2.612-614.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Poirel L, Decousser JW, Nordmann P. 2003. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M-β-lactamase gene. Antimicrob Agents Chemother 47:2938–2945. doi: 10.1128/AAC.47.9.2938-2945.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rodriguez-Martinez JM, Poirel L, Canton R, Nordmann P. 2006. Common region CR1 for expression of antibiotic resistance genes. Antimicrob Agents Chemother 50:2544–2546. doi: 10.1128/AAC.00609-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Poirel L, Bonnin RA, Nordmann P. 2011. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob Agents Chemother 55:4224–4229. doi: 10.1128/AAC.00165-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lévesque C, Brassard S, Lapointe J, Roy PH. 1994. Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 142:49–54. doi: 10.1016/0378-1119(94)90353-0. [DOI] [PubMed] [Google Scholar]
  • 7.Collis CM, Hall RM. 1995. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob Agents Chemother 39:155–162. doi: 10.1128/AAC.39.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Guérin E, Jové T, Tabesse A, Mazel D, Ploy MC. 2011. High-level gene cassette transcription prevents integrase expression in class 1 integrons. J Bacteriol 193:5675–5682. doi: 10.1128/JB.05246-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jové T, Da Re S, Denis F, Mazel D, Ploy MC. 2010. Inverse correlation between promoter strength and excision activity in class 1 integrons. PLoS Genet 6:e1000793. doi: 10.1371/journal.pgen.1000793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Papagiannitsis CC, Tzouvelekis LS, Miriagou V. 2009. Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active P2 promoter. Antimicrob Agents Chemother 53:277–280. doi: 10.1128/AAC.00912-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vinué L, Jové T, Torres C, Ploy MC. 2011. Diversity of class 1 integron gene cassette Pc promoter variants in clinical Escherichia coli strains and description of a new P2 promoter variant. Int J Antimicrob Agents 38:526–529. doi: 10.1016/j.ijantimicag.2011.07.007. [DOI] [PubMed] [Google Scholar]
  • 12.Nesvera J, Hochmannova J, Patek M. 1998. An integron of class 1 is present on the plasmid pCG4 from Gram-positive bacterium Corynebacterium glutamicum. FEMS Microbiol Lett 169:391–395. doi: 10.1111/j.1574-6968.1998.tb13345.x. [DOI] [PubMed] [Google Scholar]
  • 13.Lee AK, Falkow S. 1998. Constitutive and inducible green fluorescent protein expression in Bartonella henselae. Infect Immun 66:3964–3967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Espedido BA, Partridge SR, Iredell JR. 2008. blaIMP-4 in different genetic contexts in Enterobacteriaceae isolates from Australia. Antimicrob Agents Chemother 52:2984–2987. doi: 10.1128/AAC.01634-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jacquier H, Zaoui C, Sanson-le Pors MJ, Mazel D, Berçot B. 2009. Translation regulation of integrons gene cassette expression by the attC sites. Mol Microbiol 72:1475–1486. doi: 10.1111/j.1365-2958.2009.06736.x. [DOI] [PubMed] [Google Scholar]
  • 16.Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 17.Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22. CLSI, Wayne, PA. [Google Scholar]
  • 18.Toleman MA, Bennett PM, Walsh TR. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev 70:296–316. doi: 10.1128/MMBR.00048-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Robinson A, Brzoska AJ, Turner KM, Withers R, Harry EJ, Lewis PJ, Dixon NE. 2010. Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp. Microbiol Mol Biol Rev 74:273–297. doi: 10.1128/MMBR.00048-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gouy M, Gautier C. 1982. Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res 10:7055–7074. doi: 10.1093/nar/10.22.7055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lopes BS, Amyes SG. 2012. Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. J Med Microbiol 61:1103–1108. doi: 10.1099/jmm.0.044156-0. [DOI] [PubMed] [Google Scholar]
  • 22.Ikeda RA. 1992. The efficiency of promoter clearance distinguishes T7 class II and class III promoters. J Biol Chem 267:11322–11328. [PubMed] [Google Scholar]
  • 23.Lopez PJ, Guillerez J, Sousa R, Dreyfus M. 1997. The low processivity of T7 RNA polymerase over the initially transcribed sequence can limit productive initiation in vivo. J Mol Biol 269:41–51. doi: 10.1006/jmbi.1997.1039. [DOI] [PubMed] [Google Scholar]
  • 24.Martin CT, Muller DK, Coleman JE. 1988. Processivity in early stages of transcription by T7 RNA polymerase. Biochemistry 27:3966–3974. doi: 10.1021/bi00411a012. [DOI] [PubMed] [Google Scholar]
  • 25.Baumgardt K, Charoenpanich P, McIntosh M, Schikora A, Stein E, Thalmann S, Kogel KH, Klug G, Becker A, Evguenieva-Hackenberg E. 2014. RNase E affects the expression of the acyl-homoserine lactone synthase gene sinI in Sinorhizobium meliloti. J Bacteriol 196:1435–1447. doi: 10.1128/JB.01471-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mackie GA. 2013. RNase E: at the interface of bacterial RNA processing and decay. Nat Rev Microbiol 11:45–57. [DOI] [PubMed] [Google Scholar]
  • 27.McCarthy JE, Gerstel B, Surin B, Wiedemann U, Ziemke P. 1991. Differential gene expression from the Escherichia coli atp operon mediated by segmental differences in mRNA stability. Mol Microbiol 5:2447–2458. doi: 10.1111/j.1365-2958.1991.tb02090.x. [DOI] [PubMed] [Google Scholar]
  • 28.de Boer HA, Comstock LJ, Vasser M. 1983. The tac promoter: a functional hybrid derived from the trp and lac promoters. Proc Natl Acad Sci U S A 80:21–25. doi: 10.1073/pnas.80.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES